| Literature DB >> 29946365 |
Oumaïra Rahmouni1, Cécile Vignal1, Marie Titécat1,2, Benoît Foligné1, Benjamin Pariente1,3, Laurent Dubuquoy1, Pierre Desreumaux1,3, Christel Neut1,4.
Abstract
BACKGROUND: Adherent invasive Escherichia coli (AIEC) are suspected to be involved in the pathogenesis of inflammatory bowel diseases. Since AIEC was first described in 1999, despite important progress on its genomic and immune characterizations, some crucial questions remain unanswered, such as whether there exists a natural reservoir, or whether there is asymptomatic carriage. The ECOR collection, including E. coli strains isolated mainly from the gut of healthy humans and animals, constitutes an ideal tool to investigate AIEC prevalence in healthy condition. A total of 61 E. coli strains were examined for characteristics of AIEC.Entities:
Keywords: Adherent invasive Escherichia coli (AIEC); ECOR collection; Healthy individuals; Pathobiont
Year: 2018 PMID: 29946365 PMCID: PMC6001069 DOI: 10.1186/s13099-018-0248-7
Source DB: PubMed Journal: Gut Pathog ISSN: 1757-4749 Impact factor: 4.181
Fecal strains investigated in this study
| ID | Serotype | Phylogroup | Source | ID | Serotype | Phylogroup | Source | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Host | Sex | Location | Host | Sex | Location | ||||||
| ECOR1 | ON:HN | A | Human | Woman | USA | ECOR34 | O88:NM | B1 | Dog | USA | |
| ECOR2 | ON:H32 | A | Human | Man | USA | ECOR35 | O1:NM | D | Human | Man | USA |
| ECOR3 | O1:NM | A | Dog | USA | ECOR36 | O79:H25 | D | Human | Woman | USA | |
| ECOR4 | ON:HN | A | Human | Woman | USA | ECOR37 | ON:HN | E | Marmoset | USA | |
| ECOR5 | O79:NM | A | Human | Woman | USA | ECOR38 | O7:NM | D | Human | Woman | USA |
| ECOR6 | ON:NM | A | Human | Man | USA | ECOR39 | O7:NM | D | Human | Woman | Sweden |
| ECOR7 | O85:HN | A | Orangutan | USA | ECOR41 | O7:NM | D | Human | Man | Tonga | |
| ECOR8 | O86:HN | A | Human | Woman | USA | ECOR42 | ON:H26 | E | Human | Man | USA |
| ECOR9 | ON:NM | A | Human | Woman | Sweden | ECOR43 | ON:HN | E | Human | Woman | Sweden |
| ECOR10 | O6:H10 | A | Human | Woman | USA | ECOR44 | ON:HN | D | Cougar | USA | |
| ECOR12 | O7:H32 | A | Human | Woman | Sweden | ECOR45 | ON:HM | B1 | Pig | Indonesia | |
| ECOR13 | ON:HN | A | Human | Woman | Sweden | ECOR46 | O1:H6 | D | Celebese ape | USA | |
| ECOR15 | O25:NM | A | Human | Woman | Sweden | ECOR47 | OM:H18 | D | Sheep | New Guinea | |
| ECOR16 | ON:H10 | A | Leopard | USA | ECOR49 | O2:NM | D | Human | Woman | Sweden | |
| ECOR17 | O106:NM | A | Pig | Indonesia | ECOR51 | O25:HN | B2 | Human infant | USA | ||
| ECOR18 | O5:NM | A | Celebese ape | USA | ECOR52 | O25:H1 | B2 | Orangutan | USA | ||
| ECOR19 | O5:HN | A | Celebese ape | USA | ECOR53 | O4:HN | B2 | Human | Woman | USA | |
| ECOR20 | O89:HN | A | Steer | Bali | ECOR54 | O25:H1 | B2 | Human | USA | ||
| ECOR21 | O121:HN | A | Steer | Bali | ECOR56 | O6:H1 | B2 | Human | Woman | Sweden | |
| ECOR22 | ON:HN | A | Steer | Bali | ECOR57 | ON:NM | B2 | Gorilla | USA | ||
| ECOR23 | O86:H43 | A | Elephant | USA | ECOR58 | O112:H8 | B1 | Lion | USA | ||
| ECOR24 | O15:NM | A | Human | Woman | Sweden | ECOR59 | O4:H40 | B2 | Human | Man | USA |
| ECOR25 | ON:HN | A | Dog | USA | ECOR61 | O2:NM | B2 | Human | Woman | Sweden | |
| ECOR26 | O104:H21 | B1 | Human infant | USA | ECOR63 | ON:NM | B2 | Human | Woman | Sweden | |
| ECOR27 | O104:NM | B1 | Giraffe | USA | ECOR65 | ON:H10 | B2 | Celebese ape | USA | ||
| ECOR28 | O104:NM | B1 | Human | Woman | USA | ECOR66 | O4:H40 | B2 | Celebese ape | USA | |
| ECOR29 | O150:H21 | B1 | Kangaroo rat | USA | ECOR67 | O4:H43 | B1 | Goat | Indonesia | ||
| ECOR30 | O113:H21 | B1 | Bison | Canada | ECOR68 | ON:NM | B1 | Giraffe | USA | ||
| ECOR31 | O79:H43 | E | Leopard | USA | ECOR69 | ON:NM | B1 | Celebese ape | USA | ||
| ECOR32 | O7:H21 | B1 | Giraffe | USA | ECOR70 | O78:NM | B1 | Gorilla | USA | ||
| ECOR33 | O7:H21 | B1 | Sheep | USA | |||||||
This table was build according to data from previously published papers [19, 20]
Fig. 1Invasion score of ECOR strains of fecal origin according to their phylogroup (excluding the cell-detaching strains)
Capacity of adhesion in I-407 cells and survival and replication in macrophages among the 15 invasive strains form the ECOR collection
| ECOR strains | Mean adhesion index | Mean of bacteria recovered at 1 and 24 h postinfection (%) | |
|---|---|---|---|
| Invasive strains | ECOR1 | 197.89±29.77 | 387.47%±236.00% |
| ECOR35 | 210.53±208.41 | 881.36%±295.06% | |
| ECOR52 | 73.26±2.38 | 133.33% | |
| ECOR2 | 111.58±32.75 | 168.72%±5.67% | |
| ECOR36 | 145.26±68.48 | 511.41%±70.89% | |
| ECOR43 | 82.11±20.84 | 114.06%±142.24% | |
| ECOR44 | 334.74±229.25 | 255.70%±35.56% | |
| ECOR45 | 94.74±20.84 | 314.08%±268.26% | |
| ECOR46 | 92.63±17.86 | 70.42% | |
| ECOR7 | 170.53±74.43 | 74.51% | |
| ECOR9 | 157.89±56.57 | 152.00% | |
| ECOR15 | 153.68±44.66 | 279.07% | |
| ECOR23 | 260.63±48.23 | 395.48% | |
| ECOR67 | 67.37±23.82 | 361.90% | |
| ECOR69 | 117.89±41.68 | 887.64% | |
| Noninvasive strains | 51.58±16.38 | 24.59%±2.84 | |
| 32.21±8.30 | 87.78%±131.98% | ||
| Invasive strains | AIEC LF82 | 166.32±20.84 | 220.59% |
| AIEC NRG857c | 54.32±4.17 | 194.90%±39.93 |
Characteristics summary of invasive strains of fecal origin
| Origin | Type of strains | ID | Serotype | Phylogroup | Source | Virulence genes | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
| Humans | Invasive strains | ECOR1 | ON:HN | A | Human, USA | − | − | − | − | − | − | − | − | − | − | − | − |
| ECOR2 | ON:H32 | A | Human, USA | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR9 | ON:NM | A | Human, Sweden | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR15 | O25:NM | A | Human, Sweden | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR63 | ON:NM | B2 | Human, Sweden | − | − | − | − | − | + | − | − | − | − | − | + | ||
| ECOR35 | O1:NM | D | Human, USA | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR36 | O79:H25 | D | Human, USA | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR43 | ON:HN | E | Human, Sweden | − | − | − | − | − | − | − | − | − | − | − | − | ||
| Animals | ECOR7 | O85:HN | A | Orangutan, USA | − | − | − | − | − | − | − | − | − | − | − | − | |
| ECOR23 | O86:H43 | A | Elephant, USA | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR45 | ON:HM | B1 | Pig, Indonesia | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR67 | O4:H43 | B1 | Goat, Indonesia | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR69 | ON:NM | B1 | Celebese ape, USA | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR70 | O78:NM | B1 | Gorilla, USA | − | − | − | − | − | + | − | − | − | − | − | + | ||
| ECOR52 | O25:H1 | B2 | Orangutan, USA | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR57 | ON:NM | B2 | Gorilla, USA | − | − | − | − | − | + | − | − | − | − | − | − | ||
| ECOR44 | ON:HN | D | Cougar, USA | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR46 | O1:H6 | D | Celebese ape, USA | − | − | − | − | − | − | − | − | − | − | − | − | ||
| Humans | Cell detaching strains | ECOR6 | ON:HM | A | Human, USA | − | − | − | − | − | − | − | − | − | − | − | − |
| ECOR51 | O25:HN | B2 | Human, USA | − | − | − | − | − | − | − | − | − | − | − | + | ||
| ECOR53 | O4:HN | B2 | Human, USA | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR54 | O25:H1 | B2 | Human, USA | − | − | − | − | − | − | − | − | − | − | − | − | ||
| ECOR59 | O4:H40 | B2 | Human, USA | − | − | − | − | − | − | − | − | − | − | − | − | ||
Virulence determinants in AIEC and cell-detaching strains from the ECOR collection
| ECOR strains | Cell-detaching strains | References | ||||
|---|---|---|---|---|---|---|
| ECOR53 | ECOR51 | ECOR6 | ECOR59 | ECOR54 | ||
| Virulence determinants associated with pathogenicity islands | ||||||
| Two adhesin gene clusters sfa and pap | + pap1.2.3 | + pap1.2.3 | − | − | +sfa1.2 | Boyd et al. [ |
| The kps capsule operon | +kps1.2 | + kps1.2 | − | − | + kps1.2 | |
| The alpha-hemolysin loci hlyI and hlyII | +hly2 | +hly2 | − | − | + hly2 | |
| Haemolytic activity | ||||||
| PCR detection of the hlyA gene | + Strong haemolysis | + Strong haemolysis | ND | ND | + Strong haemolysis | Lai et al. [ |
| Distribution of STEC-lpfAs | ||||||
| Four lpfA genetic variants designated lpfAO157/OI-141, lpfAO157/OI-154, lpfAO26 and lpfAO113 | − | ND | − | − | − | Toma et al. [ |
| Antibiotic resistance in the ECOR collection | ||||||
| Streptomycin | − | − | − | − | − | Mazel et al. [ |
| Spectinomycin | − | − | − | − | − | |
| Sulfonamide | − | − | − | − | + | |
| Tetracyclin | − | − | + | − | − | |
| Ampicillin | − | − | − | − | − | |
| Kanamycin | − | − | − | − | − | |
| Chloramphenicol | − | − | − | − | − | |
| Mercuric chloride | − | − | − | − | − | |
| Ethidium bromide | − | − | − | − | − | |